From: Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
Sensitivity, %
Specificity, %
PPV, %
NPV, %
AUC (95% CI)
Cohort 1
92.50
82.50
74.60
95.10
0.936 (0.922–0.955)
Cohort 2
87.76
85.45
84.31
88.68
0.914 (0.914–0.955)